Susquehanna International Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-131,700
| Closed | -$6.8M | – | 14596 |
|
|
2022
Q3 | $6.8M | Buy |
131,700
+10,600
| +9% | +$438K | ﹤0.01% | 2695 |
|
|
2022
Q2 | $3M | Sell |
121,100
-58,000
| -32% | -$1.28M | ﹤0.01% | 4078 |
|
|
2022
Q1 | $4.49M | Sell |
179,100
-30,700
| -15% | -$863K | ﹤0.01% | 3817 |
|
|
2021
Q4 | $7.64M | Sell |
209,800
-200,100
| -49% | -$7.02M | ﹤0.01% | 3080 |
|
|
2021
Q3 | $7.01M | Sell |
409,900
-157,300
| -28% | -$2.45M | ﹤0.01% | 3399 |
|
|
2021
Q2 | $7.59M | Buy |
567,200
+552,600
| +3,785% | +$13.6M | ﹤0.01% | 3314 |
|
|
2021
Q1 | $748K | Sell |
14,600
-86,100
| -86% | -$5.18M | ﹤0.01% | 8480 |
|
|
2020
Q4 | $6.24M | Sell |
100,700
-28,200
| -22% | -$1.61M | ﹤0.01% | 3096 |
|
|
2020
Q3 | $7.06M | Sell |
128,900
-141,300
| -52% | -$7.61M | ﹤0.01% | 2635 |
|
|
2020
Q2 | $15.5M | Sell |
270,200
-16,300
| -6% | -$887K | ﹤0.01% | 1668 |
|
|
2020
Q1 | $11.5M | Buy |
286,500
+47,400
| +20% | +$2.01M | ﹤0.01% | 1597 |
|
|
2019
Q4 | $9.46M | Buy |
239,100
+1,100
| +0.5% | +$19.3K | ﹤0.01% | 2142 |
|
|
2019
Q3 | $1.61M | Buy |
238,000
+43,900
| +23% | +$329K | ﹤0.01% | 4649 |
|
|
2019
Q2 | $1.8M | Buy |
194,100
+100,600
| +108% | +$1.16M | ﹤0.01% | 4385 |
|
|
2019
Q1 | $1.3M | Buy |
93,500
+26,700
| +40% | +$305K | ﹤0.01% | 4495 |
|
|
2018
Q4 | $729K | Sell |
66,800
-6,800
| -9% | -$71.7K | ﹤0.01% | 5306 |
|
|
2018
Q3 | $930K | Buy |
73,600
+43,900
| +148% | +$529K | ﹤0.01% | 5363 |
|
|
2018
Q2 | $391K | Buy |
29,700
+17,500
| +143% | +$209K | ﹤0.01% | 7317 |
|
|
2018
Q1 | $166K | Buy |
+12,200
| New | +$126K | ﹤0.01% | 8461 |
|
|
2016
Q3 | – | Sell |
-11,400
| Closed | -$51K | – | 9249 |
|
|
2016
Q2 | $51K | Buy |
+11,400
| New | +$42.8K | ﹤0.01% | 8236 |
|
|
2015
Q4 | – | Sell |
-23,100
| Closed | -$140K | – | 10158 |
|
|
2015
Q3 | $140K | Sell |
23,100
-45,600
| -66% | -$330K | ﹤0.01% | 8963 |
|
|
2015
Q2 | $565K | Buy |
68,700
+42,400
| +161% | +$337K | ﹤0.01% | 7380 |
|
|
2015
Q1 | $199K | Sell |
26,300
-3,700
| -12% | -$28.9K | ﹤0.01% | 8639 |
|
|
2014
Q4 | $205K | Buy |
+30,000
| New | +$159K | ﹤0.01% | 8784 |
|
|
2014
Q3 | – | Sell |
-33,500
| Closed | -$196K | – | 10101 |
|
|
2014
Q2 | $196K | Buy |
33,500
+14,900
| +80% | +$83.6K | ﹤0.01% | 9096 |
|
|
2014
Q1 | $123K | Sell |
18,600
-4,900
| -21% | -$34K | ﹤0.01% | 8494 |
|
|
2013
Q4 | $136K | Sell |
23,500
-62,400
| -73% | -$322K | ﹤0.01% | 8516 |
|
|
2013
Q3 | $478K | Buy |
+85,900
| New | +$929K | ﹤0.01% | 6497 |
|
Other funds holding CCXI
Susquehanna International Group's CCXI Position: Q4 2022 in Review
Susquehanna International Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 62,963 shares — an estimated $3.25M sold.
Susquehanna International Group first reported a position in CCXI in Q4 2013 and held it in 24 quarters. The position peaked at $13.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Susquehanna International Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 62,963 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.25M.
- Susquehanna International Group first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's ChemoCentryx, Inc. position peaked at $13.5M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.